Investors Getting Picky When It Comes To Buying Coherus Biosciences Inc (CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) does about 4.95M shares in volume on a normal day but saw 2097005 shares change hands in the recent trading day. The company now has a market cap of 152.61M USD. Its current market price is $1.32, marking a decrease of -5.04% compared to the previous close of $1.39. The 52 […]
Coherus Biosciences Inc (NASDAQ: CHRS) Becomes The New Buzzing Stock: Sports A Monthly Volatility Of 9.87%
Coherus Biosciences Inc (NASDAQ:CHRS) does about 5.02M shares in volume on a normal day but saw 2352346 shares change hands in the recent trading day. The company now has a market cap of 165.91M USD. Its current market price is $1.44, marking a decrease of -2.04% compared to the previous close of $1.47. The 52 […]
Do Analysts Think Coherus Biosciences Inc (CHRS) Is Still Worth Buying In 2025?
Coherus Biosciences Inc (NASDAQ:CHRS) does about 5.24M shares in volume on a normal day but saw 3314208 shares change hands in the recent trading day. The company now has a market cap of 226.77M USD. Its current market price is $1.66, marking an increase of 18.57% compared to the previous close of $1.40. The 52 […]
Coherus Biosciences Inc (NASDAQ: CHRS): Think Like A Lender, Not An Investor
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 5.22M but it saw 2166207 shares traded in last market. With a market cap of 146.27M USD, the company’s current market price of $1.38 came falling about -8.00 while comparing to the previous closing price of $1.50. In past 52 weeks, the stock […]
Coherus Biosciences Inc (NASDAQ: CHRS) Gets A 75.17% Target Price Upside From Analysts While 125.66% Above Its 52-Week Low
Coherus Biosciences Inc (NASDAQ:CHRS) does about 5.21M shares in volume on a normal day but saw 1896976 shares change hands in the recent trading day. The company now has a market cap of 171.67M USD. Its current market price is $1.49, marking no change compared to the previous close of $1.49. The 52 week high […]
The Week Ahead: Are Investors Really Too Optimistic About Coherus Biosciences Inc (NASDAQ: CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 5.19M but it saw 1052862 shares traded in last market. With a market cap of 174.10M USD, the company’s current market price of $1.47 came rising about 2.80 while comparing to the previous closing price of $1.43. In past 52 weeks, the stock […]
Putting The Spotlight On Coherus Biosciences Inc (CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 5.19M but it saw 3153885 shares traded in last market. With a market cap of 180.88M USD, the company’s current market price of $1.57 came falling about -8.19 while comparing to the previous closing price of $1.71. In past 52 weeks, the stock […]
Do Investors Have Much Faith In Coherus Biosciences Inc (NASDAQ: CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) does about 5.27M shares in volume on a normal day but saw 2544064 shares change hands in the recent trading day. The company now has a market cap of 199.09M USD. Its current market price is $1.61, marking an increase of 7.33% compared to the previous close of $1.50. The 52 […]
Coherus Biosciences Inc (CHRS) Reports -54.05% Fall From For 52 Week High, It’s Always Darkest Before The Dawn
Coherus Biosciences Inc (NASDAQ:CHRS) does about 5.08M shares in volume on a normal day but saw 5691559 shares change hands in the recent trading day. The company now has a market cap of 220.50M USD. Its current market price is $1.70, marking no change compared to the previous close of $1.70. The 52 week high […]
With 115.21M Outstanding Shares, Can Coherus Biosciences Inc (NASDAQ: CHRS) Deliver Big Short-Term Gains?
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 4.92M but it saw 7644645 shares traded in last market. With a market cap of 173.97M USD, the company’s current market price of $1.51 came falling about -11.70 while comparing to the previous closing price of $1.71. In past 52 weeks, the stock […]
